Fuse Medical Inc (FZMD) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fuse Medical Inc   (FZMD)


Fuse Medical Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Fuse Medical Inc 's ROA in the second quarter of 2023?
Fuse Medical Inc achieved a return on average assets (ROA) of 17.34 % in its second quarter of 2023, this is above FZMD's average return on assets of -34.41%.
Fuse Medical Inc assets over the 12 months ending in its second quarter of 2023 are valued at $21 million

ROA has improved compared to 15.86% in the first quarter of 2023, due to net income growth.

However, within the Healthcare sector 45 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 276, from total ROA ranking in the first quarter of 2023 at 350.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change 11.89 % 9.33 % 18.89 % 17.58 % 5.8 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 4 3 3 -1 -2
Return On Assets (TTM) 17.34 % 15.86 % 15.53 % -4.26 % -8.21 %
FZMD's Total Ranking # 276 # 350 # 443 # 3552 # 3928
Total Assets (TTM) in million 21 19 22 21 19
Seq. Total Assets Change 9.7 % -10.7 % 2.73 % 11.18 % 7.19 %
Seq. Net Income Change - - - - -

FZMD's 5 Years Annual ROA >> Back to FZMD Management Effectiveness >> Compare FZMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 7
Sector # 46
Overall # 270

Return On Assets Statistics
High Average Low
127 %
-34.41 %
-238.29 %
(Sep 30 2013)   (Sep 30 2015)





Financial Statements
Fuse Medical Inc 's Assets $ 21 million FZMD's Balance sheet
Fuse Medical Inc 's Income $ 0 million Quarterly FZMD's Income Statement
FZMD's Income by Division See FZMD's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change 18.89 % 5.08 % -5.24 % -17.1 % 15.2 %
Total Assets in million 22 18 17 18 22
Y / Y Net Income Change - - - - 465.63 %
Net Income in million 3 -2 -1 -3 4
Annual Return On Assets 14.24 % -8.67 % -8.22 % -18.04 % 17.85 %

FZMD's 5 Years Annual ROA >> Back to FZMD Management Effectiveness >> Compare FZMD ROA to its Competitors



Comment on FZMD's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 14.24 % compared to prior year, due to annual net income growth of % to $3.10 million, while value of Fuse Medical Inc 's overall assets grew just by 18.89 % to $21.76 million, compared to $21.76 a year before.


More Return On Assets Ratios
FZMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FZMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FZMD's Competitors
Subscribers only: Roa for Fuse Medical Inc 's Suppliers
Subscribers only: Return On Assets for FZMD's Customers

You may also want to know
FZMD's Roi FZMD's Inventory Turnover Ratio FZMD's Growth Rates FZMD's Dividend Comparisons
FZMD's Profitability Ratios FZMD's Asset Turnover Ratio FZMD's Dividend Growth
FZMD's Roe FZMD's Valuation Ratios FZMD's Financial Strength Ratios FZMD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Scynexis Inc   41.74 %
Intercept Pharmaceuticals inc   39.70 %
Voyager Therapeutics Inc   38.58 %
Global Innovative Platforms Inc.  36.77 %
Shockwave Medical Inc   36.24 %
Entera Bio Ltd   35.86 %
Star Equity Holdings Inc   35.41 %
Zymeworks Inc   34.59 %
Tao Synergies Inc   34.30 %
Tenax Therapeutics Inc   31.52 %
Catalyst Pharmaceuticals Inc   29.63 %
Harmony Biosciences Holdings inc   28.68 %
Idexx Laboratories Inc  28.61 %
Semler Scientific inc   26.35 %
Assertio Holdings inc   25.11 %
Mettler toledo International Inc   23.92 %
Denali Therapeutics Inc   23.85 %
Enzo Biochem Inc  22.82 %
Nrc Health  21.88 %
Waters Corporation  21.66 %
Agile Therapeutics Inc  21.11 %
Revelation Biosciences Inc   20.17 %
Point Biopharma Global Inc   19.86 %
Medpace Holdings Inc   19.60 %
Arcturus Therapeutics Holdings Inc   19.52 %
Vaso Corporation  19.38 %
Fuse Medical Inc   18.93 %
Iradimed Corporation  18.24 %
Vertex Pharmaceuticals Inc  18.14 %
Pro dex Inc   17.44 %

Date modified: 2026-09-08T15:11:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.